Giovanni Antonini
Overview
Explore the profile of Giovanni Antonini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
183
Citations
2391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational study
Di Stefano V, Guaraldi P, Romano A, Antonini G, Barilaro A, Briani C, et al.
J Neurol
. 2025 Feb;
272(3):209.
PMID: 39954098
Background: Hereditary amyloid transthyretin amyloidosis with polyneuropathy (ATTRv-PN) is a rare, inherited, multisystemic, progressive adult-onset disease, affecting sensorimotor nerves, and various organs. It is caused by mutations in the TTR...
2.
Fionda L, Leonardi L, Tufano L, Lauletta A, Morino S, Merlonghi G, et al.
J Neurol
. 2025 Feb;
272(2):178.
PMID: 39891752
No abstract available.
3.
Pitaro M, Antonini G, Arcovito A, Buccisano F, De Lauro A, Irno Consalvo M, et al.
Front Immunol
. 2025 Jan;
15:1520103.
PMID: 39742266
Background: Mature T-cell neoplasms arise from the neoplastic transformation of a single T lymphocyte, and all cells in a neoplastic clone share the same V segment in the beta chain...
4.
Gallo V, Antonini G
Biomed Pharmacother
. 2024 Dec;
181:117743.
PMID: 39662207
Lactoferrin (Lf) is a positively charged iron-binding glycoprotein that has piqued the scientific community's interest due to its pleiotropic behavior, exhibiting a wide range of biological activities, including antimicrobial, antioxidant,...
5.
Habib A, Sacconi S, Antonini G, Cortes-Vicente E, Grosskreutz J, Mahuwala Z, et al.
Ther Adv Neurol Disord
. 2024 Sep;
17:17562864241273036.
PMID: 39297052
Background: Muscle-specific tyrosine kinase (MuSK) autoantibody-positive (Ab+) generalised myasthenia gravis (gMG) is a rare and frequently severe subtype of gMG. Objectives: To assess the efficacy and safety of rozanolixizumab in...
6.
Bortolani S, Savarese M, Vattemi G, Bonanno S, Falzone Y, Pugliese A, et al.
Neurology
. 2024 Aug;
103(4):e209697.
PMID: 39102614
Background And Objectives: The diagnostic process for myofibrillar myopathies (MFM) and distal myopathies (DM) is particularly complex because of the large number of causative genes, the existence of still molecularly...
7.
Fionda L, Leonardi L, Tufano L, Lauletta A, Morino S, Merlonghi G, et al.
J Neurol
. 2024 Jul;
271(9):5864-5874.
PMID: 38972019
Introduction: Myotonic dystrophy type 1 (DM1) is an autosomal dominant disease characterized by myotonia and progressive muscular weakness and atrophy. The aim of this study was to investigate the usefulness...
8.
Mantegazza R, Sacca F, Antonini G, Bonifati D, Evoli A, Habetswallner F, et al.
Neurol Sci
. 2024 Jul;
45(12):5671-5683.
PMID: 38967883
Myasthenia gravis (MG) is a rare, autoimmune, neurological disorder. Most MG patients have autoantibodies against acetylcholine receptors (AChRs). Some have autoantibodies against muscle-specific tyrosine kinase (MuSK) or lipoprotein-receptor-related protein 4...
9.
Arends S, Drenthen J, de Koning L, Van den Bergh P, Hadden R, Kuwabara S, et al.
Eur J Neurol
. 2024 Jul;
31(9):e16335.
PMID: 38965709
Background And Purpose: Various electrodiagnostic criteria have been developed in Guillain-Barré syndrome (GBS). Their performance in a broad representation of GBS patients has not been evaluated. Motor conduction data from...
10.
Galosi E, Costanzo R, Forcina F, Morino S, Antonini G, Salvetti M, et al.
Neurol Sci
. 2024 May;
45(10):5023-5032.
PMID: 38700599
Background: Recent evidence suggests that both serum neurofilament light chain (sNfL) levels and small fiber related diagnostic variables may be valuable disease biomarkers of hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN)....